Cleveland Clinic Identifies Melatonin as COVID-19 Treatment
Melatonin is a hormone synthesized in your pineal gland and many other organs.(1) While it is most well-known as a natural sleep regulator, it also has many other important functions.(2) For example, melatonin:
- Is a potent antioxidant(3) with the rare ability to enter your mitochondria,4 where it helps “prevent mitochondrial impairment, energy failure and apoptosis of mitochondria damaged by oxidation.”5 It also helps recharge glutathione,6 and glutathione deficiency has been linked to COVID-19 severity
- Plays an important role in cancer prevention7
- Is important for brain, cardiovascular and gastrointestinal health8
- Boosts immune function in a variety of ways
- May improve the treatment of certain bacterial diseases, including tuberculosis9
- Helps quell inflammation
- May prevent or improve autoimmune diseases, including Type 1 diabetes10
- Is an important energy hormone that can influence your energy level11
- Helps regulate gene expression via a series of enzymes12
- Has anticonvulsant and antiexcitotoxic properties13
Melatonin has also been shown to play a role in viral infections14 and according to a June 2020 research paper15,16,17 in Life Sciences journal, it may be an important adjunct to COVID-19 treatment. According to the authors, melatonin attenuates several pathological features of COVID-19, including:18
- Excessive oxidative stress and inflammation
- Exaggerated immune response resulting in a cytokine storm
- Acute lung injury
- Acute respiratory distress syndrome
The scientific review paper,20 “Melatonin Potentials Against Viral Infections Including COVID-19: Current Evidence and New Findings,” published October 2020 in Virus Research journal, also summarizes the many potential mechanisms by which melatonin can protect against and ameliorate viral infections.
The authors review research looking at melatonin’s beneficial effects against a variety of viruses, including respiratory syncytial virus, Venezuelan equine encephalitis virus, viral hepatitis, viral myocarditis, Ebola, West Nile virus and dengue virus. Based on these collective findings, they believe melatonin may offer similar protection against SARS-CoV-2.
Melatonin Reduces Risk of Positive COVID-19 Test
Data21,22 from Cleveland Clinic also supports the use of melatonin. Here, the researchers analyzed patient data from the Cleveland Clinic’s COVID-19 registry using an artificial intelligence platform designed to identify drugs that may be repurposed.23,24
"Patients who used melatonin as a supplement had, on average, a 28% lower risk of testing positive for SARS-CoV-2. Blacks who used melatonin were 52% less likely to test positive for the virus."
“Analyses of single-cell RNA sequencing data show that co-expression of ACE2 and TMPRSS2 is elevated in absorptive enterocytes from the inflamed ileal tissues of Crohn disease patients compared to uninflamed tissues, revealing shared pathobiology between COVID-19 and inflammatory bowel disease.
Integrative analyses of metabolomics and transcriptomics (bulk and single-cell) data from asthma patients indicate that COVID-19 shares an intermediate inflammatory molecular profile with asthma (including IRAK3 and ADRB2).”
The diagram below illustrates (among other things) the basic pathogenesis of SARS-CoV-2 (figure A) and the network of disease manifestations associated with the infection (figure C).
These connections suggest that drugs already in use for a chronic disease may be repurposed and used in the treatment of COVID-19, as it acts on one or more shared biological targets. Melatonin stood out in this regard. Patients who used melatonin as a supplement had, on average, a 28% lower risk of testing positive for SARS-CoV-2. Blacks who used melatonin were 52% less likely to test positive for the virus.
Confounding variables adjusted for in the calculations included age, sex, race, smoking history and several known comorbidities. The authors point out that while the findings look promising, large observational studies and randomized controlled trials are still needed to validate the clinical benefits of melatonin.
Two key data points missing from the analysis are the dosage used and the length of supplementation. These data were not included in the patient registry, so we don’t know how much melatonin is required to lower your risk of SARS-CoV-2 infection to the degree found in this study.
High-Dose Melatonin Successfully Treats COVID-19
It’s possible that higher doses than those used for sleep may be needed, at least when treating an active infection. A recent case series26 published in the journal Melatonin Research details how high-dose intravenous melatonin can benefit patients with COVID-19 pneumonia.
Here, patients were given 36 mg to 72 mg per day in four divided doses as an adjunct therapy to standard of care. Most supplements contain between 0.5 mg and 5 mg, and when used for sleep, you’d typically start with the lowest dose and work your way up as needed.
All of the patients given melatonin improved within four to five days, and all survived. On average, those given melatonin were discharged from the hospital after 7.3 days, compared to 13 days for those who did not get melatonin. This is far better than the expensive treatment Remdesivir, which costs over $3,000 and doesn’t produce anywhere near this improvement.
Other Doctors Are Also Using Melatonin Against COVID-19
Dr. Richard Neel and colleagues at Little Alsace and Uvalde Urgent Care clinics in Texas also report using high-dose melatonin in combination with vitamin C and vitamin D, and had as of the last week of July 2020 successfully treated more than 400 patients.27
As reviewed in a section below, melatonin enhances vitamin D signaling and the two work synergistically to enhance your mitochondrial function. Melatonin and vitamin C are both also involved with ACE2, the receptor that SARS-CoV-2 uses to gain entry into the cell.
Together, melatonin and vitamin C help reduce SARS-CoV-2 virulence by inhibiting NLRP3 inflammasomes, which in turn inhibits cytokine storms. The Front Line COVID-19 Critical Care Working Group (FLCCC)28 also lists melatonin as an optional addition to their MATH+ protocol for COVID-19.
Research suggests melatonin may have the ability to combat COVID-19 via several different mechanisms. For example, it’s been shown to regulate immune responses and prevent cytokine storms.29 As explained by the authors of one such study,30 when your immune cells are in a hyper-inflammatory state, their metabolism changes in a way similar to that of cancer cells:
“Similar to cancer cells … immune cells such as macrophages/monocytes under inflammatory conditions abandon mitochondrial oxidative phosphorylation for ATP production in favor of cytosolic aerobic glycolysis (also known as the Warburg effect) …
The change to aerobic glycolysis allows immune cells to become highly phagocytic, accelerate ATP production, intensify their oxidative burst and to provide the abundant metabolic precursors required for enhanced cellular proliferation and increased synthesis and release of cytokines ...
Because of melatonin's potent antioxidant and anti-inflammatory activities, it would normally reduce the highly proinflammatory cytokine storm and neutralize the generated free radicals thereby preserving cellular integrity and preventing lung damage.”
Cytokine storm is one of the reasons why sepsis (blood poisoning) is so lethal, and studies have confirmed melatonin has a favorable influence on sepsis. (Sepsis is also a feature of severe COVID-19.) As reported in a 2010 study in the Journal of Critical Care:31
“Melatonin is an effective anti-inflammatory agent … Its anti-inflammatory action has been attributed to inhibition of nitric oxide synthase with consequent reduction of peroxynitrite formation, to the stimulation of various antioxidant enzymes thus contributing to enhance the antioxidant defense, and to protective effects on mitochondrial function and in preventing apoptosis.
In a number of animal models of septic shock, as well as in patients with septic disease, melatonin reportedly exerts beneficial effects to arrest cellular damage and multiorgan failure …
Apart from action on the local sites of inflammation, melatonin also exerts its beneficial actions through a multifactorial pathway including its effects as immunomodulatory, antioxidant and antiapoptotic agent.”
More recently, a 2019 animal study32 in the journal Frontiers in Immunology discusses how melatonin can protect against polymicrobial sepsis — i.e., sepsis caused by more than one microbial organism — which has a twofold higher lethality than unimicrobial sepsis (sepsis caused by a single microbe).33
In this case, melatonin appears to offer protection by having an antibacterial effect on white blood cells called neutrophils. A high neutrophil count is an indicator for infection. Melatonin may also combat SARS-CoV-2 infection by:34
- Suppressing oxidative stress35
- Regulating blood pressure (a risk factor for severe COVID-19)
- Improving metabolic defects associated with diabetes and insulin resistance (risk factors for severe COVID-19) via inhibition of the renin-angiotensin system (RAS)
- Protecting mesenchymal stem cells (MSCs, which have been shown to ameliorate severe SARS-CoV-2 infection) against injuries and improving their biological activities
- Promoting both cell-mediated and humoral immunity
- Promoting synthesis of progenitor cells for macrophages and granulocytes, natural killer (NK) cells and T-helper cells, specifically CD4+ cells
- Inhibiting NLRP3 inflammasomes36
As mentioned, it’s very difficult to make dosage recommendations based on the limited evidence currently at hand, but since Cleveland Clinic looked at the supplements patients reported using, it seems reasonable to assume they were using it as you typically would. Most melatonin supplements contain between 0.5 mg and 5 mg.
In the case report mentioned earlier, patients were given 36 mg to 72 mg of melatonin intravenously per day, which would likely be excessive for prophylactic use. That said, research37 has found no adverse effects for dosages ranging from 20 mg up to 100 mg.
Whatever dose you take, and I recommend starting low, at 1 mg or less, be sure to take melatonin at night, before bed. Rising melatonin levels is the reason you feel sleepy in the evening, so it’s ill advised to take it in the morning or during the day, when your natural level is (and should be) low. If you happen to wake up in the middle of the night, especially if you’re exposed to a light source, you could also take some then, to help you go back to sleep.
Melatonin is also best taken sublingually, either in the form of a spray or sublingual tablet. Sublingually, it can enter your blood stream directly and doesn’t have to go through the digestive tract. As a result, its effect will be felt more rapidly.
Melatonin and Vitamin D Are a Winning Combo
Another supplement of crucial importance in the age of COVID-19 is vitamin D. Interestingly, melatonin enhances vitamin D signaling, and optimizing your vitamin D may be one of the most beneficial steps you can take to lower all of the risks associated with COVID-19, from reducing your risk of testing positive to lowering your risk of severe infection and death.
Together, melatonin and vitamin D synergistically act to optimize your mitochondrial function. In fact, your mitochondria are the final common target for both.38
A deficiency in either vitamin D or melatonin has been associated with the pathogenesis of several chronic diseases, including high blood pressure, cardiovascular disease, metabolic syndrome and diabetes, just to name a few.39
These conditions have also emerged as co-morbidities that significantly raise your risk of death from COVID-19. Synthesis of both vitamin D and melatonin is also dramatically reduced with advancing age, and old age is a primary risk factor for COVID-19 death. So, while vitamin D3 and melatonin supplementation may be beneficial for most people, it’s particularly important for the elderly.
Support Your Body’s Production of Melatonin and Vitamin D
Keep in mind, however, that it makes little sense to take a supplement unless you’re also seeking to optimize your body’s natural production. In the case of melatonin, this includes making sure you get good sleep on a regular basis.
You also need a good dose of natural sunlight around midday to synchronize your circadian clock so that your body produces melatonin at the appropriate time (i.e., in late evening). As the evening wears on and the sun sets, you’ll want to avoid bright and all blue lighting, as blue light inhibits melatonin synthesis. Blue lighting is predominant in LED and fluorescent bulbs that are “cool white.”
If for whatever reason you cannot get sufficient amounts of sun exposure, consider taking a vitamin D3 supplement (along with a little extra vitamin K2 to maintain a healthy ratio between these two nutrients).
- 1, 14, 31 Journal of Critical Care 2010 Dec;25(4):656.e1-6
- 2 Pharmacological Research April 2012; 65(4): 437-444
- 3 Journal of Pineal Research December 17, 2002; 34(1)
- 4 The Journal of Steroid Biochemistry and Molecular Biology May 2020; 199: 105595, Page 13
- 5, 12, 13 Front Biosci. 2007 Jan 1;12:947-63
- 6 Neuro Endocrinol Lett. 2006 Jun;27(3):365-8
- 7 International Journal of Molecular Sciences, 2013 Jan 24;14(2):2410-30
- 8 Current Neuropharmacology, 2017 Apr;15(3):434-443
- 9 Antimicrobial Agents and Chemotherapy, 1999 Apr;43(4):975-7
- 10 International Journal of Molecular Sciences, 2013 Apr; 14(4):8638-8683
- 11 Stanford University, Melatonin and Energy Levels, Sierra Kersten, May 24, 2018
- 15, 18 Life Sciences June 1, 2020; 250:117583
- 16 Psychology Today May 8, 2020
- 17 Chronobiology Melatonin May Help Fight Coronavirus
- 19 Life Sciences June 1, 2020; 250:117583, Abstract
- 20, 34 Virus Research October 2, 2020; 287: 198108
- 21, 23, 25 PLOS Biology November 6, 2020 DOI: 10.1371/journal.pbio.3000970
- 22, 24 Cleveland Clinic November 9, 2020
- 26 Melatonin Research 2020; 3(3)
- 27 Devinenews.com July 22, 2020
- 28 Front Line COVID-19 Critical Care Working Group (FLCCC)
- 29, 30 Medical Drug Discoveries June 2020; 6:100044
- 32 Frontiers in Immunology 2019 Jun 19;10:1371
- 33 Critical Care 2010; 14(Suppl 1): P62
- 35 Current Neuropharmacology 2010 Sep; 8(3): 228–242
- 36 Evolutamente.it March 14, 2020
- 37 Journal of Pineal Research 2014 May;56(4):427-38, Abstract
- 38, 39 The Journal of Steroid Biochemistry and Molecular Biology May 2020; 199: 105595